Le marché des services de FIV était évalué à 13 496,29 millions de dollars américains en 2019 et devrait atteindre 31 613,76 millions de dollars américains d'ici 2027 ; il devrait croître à un TCAC de 11,6 % de 2020 à 2027.
La FIV ou la fécondation in vitro est une technologie de reproduction à la mode dans laquelle les ovules des ovaires de la femme et l'échantillon de sperme d'un homme sont récupérés et diffusé manuellement à l'extérieur dans une capsule en verre de laboratoire. Après la fécondation, ces ovules fertiles subissent une culture d'embryons pendant quelques jours et sont transférés dans le même utérus ou dans l'utérus d'une autre femme pour établir une grossesse réussie.
Le marché des services de FIV est segmenté en fonction du type de cycle, de l'utilisateur final , et géographie. Sur la base de la géographie, le marché est segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique et en Amérique du Sud et centrale. Le rapport offre des informations et une analyse approfondie du marché des services de FIV en mettant l'accent sur divers paramètres tels que les tendances du marché, les progrès technologiques, la dynamique du marché et l'analyse du paysage concurrentiel des principaux acteurs du marché à travers le monde. Il comprend également une analyse d'impact du COVID-19 dans toutes les régions. On estime que le marché devrait croître à un rythme plus lent au cours de la période de prévision en raison de la baisse des services de FIV pendant la pandémie de COVID-19 qui a entraîné un verrouillage strict de certains services de santé.
Régions lucratives pour Marché des services de FIV
Aperçu du marché
Augmentation de l'incidence de l'infertilité
Le taux de fécondité diminue régulièrement à l'échelle mondiale en raison de divers facteurs, tels que la tendance croissante des mariages tardifs et augmentation de l'infertilité liée à l'âge. Les taux de fécondité mondiaux devraient chuter à 2,4 enfants par femme d'ici 2030 et à 2,2 enfants par femme d'ici 2050. Environ 12 % des femmes âgées de 15 à 44 ans aux États-Unis ont eu des difficultés à tomber enceintes ou à mener une grossesse à terme, quel que soit leur état matrimonial. . De plus, environ 6,0% des femmes mariées âgées de 15 à 44 ans aux États-Unis sont incapables de tomber enceinte après un an d'essai (infertilité). Selon le National Center for Health Statistics, le taux de natalité aux États-Unis en 2018 était estimé à 11 968 naissances pour 1 000 personnes, soit une baisse de 0,95 % par rapport à 2017. De plus, les maladies à chlamydia causent environ 4 à 5 millions d'infections par an aux États-Unis. S'il n'est pas traité à temps, il peut entraîner l'infertilité chez les hommes et les femmes.
De plus, selon le Rapport mondial sur la fertilité 2019, des estimations des taux de natalité chez les adolescentes sont disponibles pour 2015-2020 pour 201 pays ou régions avec population d'au moins 90 000 habitants. Des déclins rapides de la fécondité ont été observés dans toutes les grandes régions. Parmi les 77 pays et zones où la fécondité des adolescentes a diminué de plus de 50 % entre 1990-1995 et 2015-2020, 28 se trouvaient en Europe, 28 en Asie, 8 en Afrique (Algérie, Botswana et autres), 7 dans les Caraïbes (Bahamas, Porto Rico, Grenade, Aruba, Martinique, Sainte-Lucie et les îles Vierges américaines), 4 en Océanie (Guam, Kiribati, Micronésie et Nouvelle-Calédonie), ainsi qu'au Canada et aux États-Unis. Ainsi, la baisse du taux de fécondité entraîne une augmentation significative de la demande de services de fécondation in vitro (FIV) qui déterminent la fenêtre de fécondité chez les hommes et les femmes.
Cycle Type-Based Insights
Sur la base du type de cycle, le marché des services de FIV est segmenté en cycles de FIV frais, cycles de FIV décongelés et cycles de FIV d'ovules de donneur. Le segment des cycles de FIV frais détenait la plus grande part du marché en 2019, et le même segment devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Marché mondial des services de FIV, par type de cycle - 2019 et 2027
Informations basées sur l'utilisateur final
En fonction de l'utilisateur final, le marché des services de FIV est segmenté en hôpitaux, cliniques de fertilité, centres chirurgicaux et instituts de recherche clinique. Le segment des cliniques de fertilité détenait la plus grande part du marché en 2019 ; et le même segment devrait enregistrer un TCAC sur le marché au cours de la période 2020-2027.
Perspectives stratégiques
Les stratégies inorganiques telles que les partenariats et les fusions et acquisitions sont couramment adoptées par les entreprises pour répondre l'évolution de la demande des clients et de maintenir leurs services améliorés à travers le monde. Les acteurs du marché opérant sur le marché des services de FIV adoptent également des stratégies organiques telles que le lancement et l'expansion de produits pour étendre leur empreinte et leur portefeuille de produits dans le monde entier ainsi que pour répondre à la demande croissante.
Par type de cycle
< ul>
Par utilisateur final
- Cliniques de fertilité
- Hôpitaux
- Centres chirurgicaux et instituts de recherche clinique
Par géographie
- Nord Amérique
- États-Unis
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Asie-Pacifique (APAC)
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'APAC
- Moyen-Orient et Afrique (MEA)
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste de la MEA
- Amérique du Sud et centrale (SCAM)
- Brésil < li>Argentine
- Reste de SCAM
Profils d'entreprise
- Max Healthcare
- Bloom IVF
- CCRM Fertility.
- OXFORD FERTILITY
- Create Health (Create Fertility)
- Medicover < li>Clinique de fertilité Aevitas
- Clinique de fertilité BIOART
- Prelude Fertility, Inc.
- Don de la vie
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
IVF or in-vitro fertilization is a hyped reproductive technology in which the ova from woman's ovaries and the sperm sample from a male is retrieved and manually diffused externally in a laboratory glass dish. After the fertilization these fertile eggs undergo embryo culture for a few days and transferred to the same or another woman's uterus in order to establish a successful pregnancy.
Key factors that are driving growth of the market are increasing incidence of infertility, rising number of fertility clinics and infertility services with government support and growing number of products launches and developments. However, the high procedural cost of reproductive techniques and risks associated with infertility treatment hinders the market growth. Moreover, the increasing trend of delayed pregnancy is contributing to the higher adoption of IVF techniques.
The cost of IVF service depends upon the IVF cycle performed, which nearly starts from US$ 15,000 or more. The cost may further increase along with the associated procedures such as ultrasounds, blood tests, lab work, and embryo storage among others.
The List of Companies - IVF Services Market
- Max Healthcare
- Bloom IVF
- CCRM Fertility.
- OXFORD FERTILITY
- Create Health (Create Fertility)
- Medicover
- Aevitas Fertility Clinic
- BIOART Fertility Clinic
- Prelude Fertility, Inc.
- Gift ov life
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)